Author:
Gong Hang,Zhong Huang,Xu Hui-Mei,Liu Xiong-Chang,Li Liang-Ping,Zhang De-Kui
Reference157 articles.
1. Nonalcoholic fatty liver disease (nafld). Mitochondria as players and targets of therapies?;Di Ciaula;Int J Mol Sci,2021
2. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits;Speliotes;PLoS Genet,2011
3. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016
4. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in asia, 1999-2019: a systematic review and meta-analysis;Li;Lancet Gastroenterol Hepatol,2019
5. Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study;Lesmana;Diabetes Metab Syndr Obes,2015